Interv Akut Kardiol. 2006;5(4):147-148
Interv Akut Kardiol. 2006;5(4):157-162
We are introducing retrospective analysis of treatment of 229 patients with acute pulmonary embolism (PE), representing 0.83 % of all 27 747 patients who were hospitalized in our clinic between 1996 and 2005. Aim: We concentrated on thrombolytic treatment (TT) especially in patients with acute non massive PE and right ventricular dysfunction (RVD). Study group and methods: Out of 229 patients (119 women) 42 patients had massive PE, 184 patients had non massive PE and 103 of them RVD on baseline echocardiography and 3 patients had chronic thromboembolic pulmonary hypertension. 73 patients were treated with thrombolysis (32 patients with...
Interv Akut Kardiol. 2006;5(4):163-166
The aim: to evaluate guidelines adherence in the treatment of patients with ST elevation myocardial infarction (STEMI) in the area served by the department of internal medicine and by the emergency care (first aid squads) in Semily. Study population: 26 patients presented with STEMI to our hospital or to the emergency care in the area served in 2005. 15 of them were males (57.7 %), the average age was 63 years (51–84 years) and 11 females (42.3 %), the average age was 66.7 years (52–86 years). The first contact of a patient with a medical provider took place at home in 21 cases, 5 times in the hospital. In 8 cases of first...
Interv Akut Kardiol. 2006;5(4):168-173
Relative incompetence is the most common acquired disorder of the tricuspid valve. It develops as a late result of the left-heart valve disease – mitral stenosis/regurgitation, aortic stenosis. Surgical treatment of relative tricuspid incompetence is based on remodeling of the dilated tricuspid annulus or, rarely, a valve replacement. Surgery is clearly indicated in severe tricuspid regurgitation. In mild or moderate regurgitation the indication remains disputable due to uneasy prediction of the course of pulmonary hypertension and right ventricular dysfunction following correction of left-heart valve disease. Recent cardiosurgical opinion, however,...
Interv Akut Kardiol. 2006;5(4):174-180
Diabetes mellitus (DM) plays a key prognostic role in patients with acute coronary syndromes (ACS). Admission plasma glucose is an independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients(14). There are studies indicating that patients with prediabetic conditions, such as impaired glucose tolerance (IGT), also have an increased risk for complications and mortality after ACS. Postprandial glucose level has been reported to be a better risk predictor for coronary heart disease and cardiovascular mortality than fasting glucose. For the proper management of patients with ACS it is vitally important to identify...
Interv Akut Kardiol. 2006;5(4):181-182
Idiopathic recurrent effusive pericardiopathy often poses a major clinical challenge. Its management is difficult and frequently involves repeat pericardiocentesis and/or elective surgery. Alternatives include catheterization techniques, with our attention focused on the cutting pericardiotome: the following is the case report of our first clinical case at an interval of seven years.
Interv Akut Kardiol. 2006;5(4):183-185
Our patient was admitted to the Cardiology Department for acute progressive dyspnea and faintness. Working diagnosis at the time of the first contact was acute pulmonary embolism. Echocardiographic examination revealed acute severe aortic regurgitation caused by valve destruction with signs of acute severe volume overload of the left ventricle. Patient has had history of Crohn Disease with severe affection of terminal part of ileum and Bauhinian valve. In obtained blood cultures, infective agent Enteroccocus faecalis was identified, so prompt correct diagnosis of acute infective endocarditis (IE) as a complication of Crohn Disease was set. Patient...
Interv Akut Kardiol. 2006;5(4):156
Interv Akut Kardiol. 2006;5(4):189-190
Interv Akut Kardiol. 2006;5(4):186-188
Clinical trial CHARISMA showed that long-term dual antiplatelet therapy with combination of clopidogrel and aspirin in patients with manifest cardiovascular disease or multiple risk factors did not improve efficacy and increased risk of bleeding. Subgroup analysis seems to show different therapeutic results in primary and secondary prevention.